Moreover, the combined expression of H2AFJ and HDAC3 was appeared to be inversely correlated with the time to new tumor event after TMZ therapy in the wild-type IDH1/non-G-CIMP GBM patients (Figure 6G). This evidence concerns the gene IDH1 and neoplasm.